ROY GERNHARDT: Open Payments
NPI 1215071972 · FORTY FORT, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 24 payments from 15 companies in 2025. Trend: 2023 $375 · 2024 $187 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $81 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $66 |
| Novo Nordisk Inc | 2 | $34 |
| PFIZER INC. | 2 | $30 |
| Lilly USA, LLC | 2 | $30 |
| Exact Sciences Corporation | 1 | $29 |
| Braeburn Inc. | 1 | $22 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Kerendia, VRAYLAR, JARDIANCE, PREVNAR 20, Cologuard Collection Kit, UBRELVY, BRIXADI, QULIPTA.
Industry payments across PA — which companies pay providers there.
